Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients (DOPPLER-CIP)

Coronary artery disease (CAD) remains the primary cause of cardiovascular morbidity and mortality in Europe. In current clinical practice, patients with chronic CAD are followed using non-invasive imaging methodologies for possible adverse morphologic remodelling and functional recovery of the myocardium before the decision for invasive examinations and treatments is taken. Technological developments have brought about several newer imaging methodologies (and associated parameters) that have shown accurate prognostic results under study conditions in selected patient populations. Each of these methodologies offers intrinsic advantages and disadvantages due to the physiologic processes it tries to assess, due to the technology it requires or due to its availability (often determined by its associated cost). However, to date, no large scale studies have made a direct comparison of the different methodologies towards predicting adverse morphologic remodelling or functional recovery of the myocardium after medical therapy. The lack of such information results in a sub-optimal use of the methodologies at hand. The aim of DOPPLER-CIP is therefore to conduct a multi-centre clinical study including about 1200 patients in order to determine the optimal prognostic parameters derived from (new) non-invasive imaging for a patient presenting with suspected chronic ischemic heart disease. The modality used to extract these parameters is of secondary importance. However, as both the accuracy and the cost related to extracting a particular parameter is modality-dependent, DOPPLER-CIP will also make a cost-effective analysis in order to determine which modality should preferentially be used to extract the clinically most relevant parameter. The study is financed by the European Union and is coordinated from Leuven, Belgium with cooperating centers in Linkoping, London, Madrid, Oslo, Pisa and Turku. Several add-on studies in Linköping will have access to this wealth of patient data for more in-depth analysis of wall motion and blood flow.

• Staff:

Tino Ebbers , PhD		Scientific Team Leader Linköping		Linköping university
Jan Engvall , MD PhD		Overall Work Package Leader Morphology		Linköping university

• Former Staff:

• Project Description:

More information can be found at www.doppler-cip.eu.